跳至主要内容
临床试验/NCT00564356
NCT00564356Unknown不适用

The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2007年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
75
试验地点
1
主要终点
safety and efficacy of cataract surgery with phacoemulsification under coumadin and antiaggregant treatment

研究概览

简要总结

To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification in patients on coumadin and antiaggregant treatments.

Design: Consecutive prospective study.

详细描述

To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification technique in patients on coumadin and antiaggregant treatment Design: Consecutive prospective study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • patients who give informed consent to participate in the study

排除标准

  • single eye complicated cataract

结局指标

主要结局

safety and efficacy of cataract surgery with phacoemulsification under coumadin and antiaggregant treatment

时间窗: 3.5 years

次要结局

  • other complications(3.5 years)

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验

The Safety of Cataract Removal by... | 临床试验